Cargando…
Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma
The aim of this study was to evaluate the efficacy and safety of antiulcer oral mucosal protectant-RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions elicited during intensity-modulated radiation therapy (IMRT). for locally advanced nasopharyngeal carcinoma (NPC)....
Autores principales: | Yin, Jun, Xie, Jirui, Lin, Jiawei, Weng, Chengyin, Lu, Shun, Xu, Peng, Zhang, Shuo, Luo, Cheng, Huang, Yecai, Li, Lu, Lang, Jinyi, Feng, Mei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812764/ https://www.ncbi.nlm.nih.gov/pubmed/34989325 http://dx.doi.org/10.1080/15384047.2021.2013704 |
Ejemplares similares
-
Oral mucositis induced by anticancer treatments: physiopathology and treatments
por: Lionel, D'Hondt, et al.
Publicado: (2006) -
Prevention and Treatment of Chemotherapy and Radiotherapy Induced Oral Mucositis
por: Daugėlaitė, Goda, et al.
Publicado: (2019) -
Radiation Induced Oral Mucositis
por: PS, Satheesh Kumar, et al.
Publicado: (2009) -
Radiation-Induced Oral Mucositis
por: Maria, Osama Muhammad, et al.
Publicado: (2017) -
Effect of Kangfuxin Solution on Chemo/Radiotherapy-Induced Mucositis in Nasopharyngeal Carcinoma Patients: A Multicenter, Prospective Randomized Phase III Clinical Study
por: Luo, Yangkun, et al.
Publicado: (2016)